Jury Finds Zantac Not Responsible for Illinois Woman's Colon Cancer

The verdict marks the first trial win for drugmakers GSK and Boehringer Ingelheim among thousands of similar lawsuits.

Angela Valadez claimed Zantac caused her colon cancer after using it for nearly 20 years.
The jury concluded there was insufficient evidence linking Zantac to her cancer.
Defendants GSK and Boehringer argued that scientific studies do not support claims that Zantac causes cancer.
This case is the first of many pending lawsuits alleging Zantac's cancer risk.
Both companies plan to vigorously defend against future claims.